Terumo Corp.

Terumo Corp.

Terumo Corp.

Date Founded



2-44-1 Hatagaya, Shibuya-ku, Tokyo, 151-0072, JPN

Type of Company


Employees (Worldwide)



Industrial Machinery & Manufacturing
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services

Company Description

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: General Hospital, Cardiac & Vascular, and Blood Management. The General Hospital segment produces, supplies, leases, and sells hospital equipment, pharmaceutical, home medical treatment, and peritoneal dialysis and diabetes-related products. The Cardiac & Vascular segment imports and merchandises catheter and cardiovascular systems products. The Blood Management segment manufactures and sells blood transfusion products such as blood bags and automated blood component processing devices. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan

Executives & Employees

President & Chief Executive Officer


Senior Executive Officer & General Manager, Research & Development

Chief Technology Officer, Executive Officer, GM-Research & Development

General Manager-Sales Management Department

Chief Legal Officer & General Manager-Compliance

Executive Officer & Head-Healthcare Company

Head-Investor Relations, Legal & Compliance

Chief Clinical & Regulatory Affairs Officer

Chief Accounting & Financial Officer

Subscribe now to see full list of current and former executives
Board of Directors

Chairman at Terumo Corp.

Partner at Mori Hamada & Matsumoto

President & Chief Executive Officer at Terumo Corp.

President & Chief Executive Officer at Terumo BCT Holding Corp.

Senior Executive Officer & General Manager, Research & Development at Terumo Corp.

Auditor at Terumo Corp.

Auditor at Terumo Corp.

Former Chairman & Chief Executive Officer at Subaru Corp.

Director & Managing Executive Officer at Terumo Corp.

Subscribe now to see full list of current and former board members
Paths to Terumo Corp.
Potential Connections via
Relationship Science
Terumo Corp.
Owners & Shareholders
Details Hidden

NAM-J is an active, value-oriented manager with a global perspective and a medium- to long-term outlook. Their investment philosophy emphasizes multi-faceted research shared internationally throughout the group, and local expertise contributed by their overseas offices. Their strong research capabilities, supported and integrated globally by proprietary systems, include fundamental analysis, company visits, market research, credit analysis, macroeconomic projections and quantitative analysis. Their global asset allocation strategy is determined by an investment committee at the group level.The firm uses a variety of strategies including active, passive and active quantitative. Their funds are invested in domestic and global equity and fixed-income, as well as in Japanese money market instruments. The majority of their investments are in equity, complemented by a substantial minority of bonds and investments in private placement funds. The firm manages a range of Japanese ETFs including sector funds.NAM-J's investment process is team-based and combines bottom-up and top-down strategies, with a bias towards stockpicking.

Details Hidden

Daiwa AM is an active, mid-to long-term manager which seeks to identify hidden values which are not yet fully recognized in the market through a balanced approach emphasizing fundamental and quantitative analysis. They conduct in-house research and have a strong global research network.The firm’s basic assumption is that the market is not fully efficient and they employ a coherent investment process through organizational support at each phase of their 'Plan', 'Do' and 'Review' policy. They pursue stable excess mid-to long-term returns through suitable risk control, which they separate from investment management to ensure that the risk control system adequately monitors their investment process. Daiwa AM’s research team analysts and portfolio managers discuss, evaluate and communicate market events and investment opinions, seeking to maximize portfolio performance. Company visits are important components of their bottom-up research process and are a primary source for their fundamental analysis.

Details Hidden

MFSI UK is a team-based manager which seeks to help clients build diversified portfolios using the \"ADR\" strategy; Allocate across asset classes, Diversify within each class, and Rebalance regularly to maintain the desired allocation.The firm follows a proprietary bottom-up security-selection process, known as MFS Original Research, with which they seek to take advantage of investment opportunities in capital markets across asset classes globally.MFSI UK's research analysts develop in-depth, firsthand knowledge of companies and make assessments of their long-term prospects. The firm's analysts and portfolio managers then exchange opinions and challenge ideas in a spirit of collaboration.Portfolio managers construct diversified portfolios by combining analysts' recommendations and their own experience to select securities that match their portfolio's investment discipline. The firm's quantitative teams help ensure that the risk levels they assume are appropriate for the portfolio's objectives.

Subscribe now to see full details
Recent Transactions
Details Hidden

Terumo Corp. purchases Bolton Medical, Inc. from Werfen Group SA

Details Hidden

Terumo Corp. purchases Abbott Laboratories /Medical Device Business from Abbott Laboratories

Details Hidden

MicroVention, Inc., Terumo Corp. purchase Sequent Medical, Inc. from U.S. Venture Partners, Domain Associates LLC, Delphi Ventures, Inc., Versant Venture Management LLC

Subscribe now to see full list of recent transations
Transaction Advisors
Legal Advisor

Advised onTerumo Corp. purchases CaridianBCT, Inc. from Indap Sweden AB, Investor AB, EQT Partners AB

Investment Advisor

Advised onTerumo Corp. purchases Bolton Medical, Inc. from Werfen Group SA

Investment Advisor

Advised onTerumo Corp. purchases CardioVascular Systems, Inc. (Inactive) from 3M Company

Subscribe now to see 8+ more transaction advisors
Legal Advisor

Advised onTerumo Corp. purchases CaridianBCT, Inc. from Indap Sweden AB, Investor AB, EQT Partners AB

Legal Advisor

Advised onTerumo Corp. purchases CaridianBCT, Inc. from Indap Sweden AB, Investor AB, EQT Partners AB

Legal Advisor

Advised onTerumo Corp., Terumo Medical Corp. purchase Harvest Technologies Corp.

Subscribe now to see 8+ more transaction advisors

FUJIFILM Holdings, Inc. engages in the development, production, sales and service of imaging, information, and document solutions. It operates through the following segments: Imaging Solutions, Information Solutions, and Document Solutions. The Imaging Solutions segment handles color films, digital cameras, optical devices, color paper, services and equipment for photofinishing, instant photo systems, etc. The Information Solutions segment deals with the equipment and materials for medical systems, life sciences products, pharmaceuticals, graphic arts, flat panel display materials, recording media and electronic materials, etc. The Document Solutions segment provides office copy machines/MFPs, printers, production systems and services, office services, paper and consumables, etc. The company was founded on January 20, 1934 and is headquartered in Tokyo, Japan.

Our customers are at our heart. As a diversified conglomerate we serve our local and international customers across varied spheres in their lives; we are quite pleased to have grown with them over the years as a trustworthy brand. The Group, founded by Sheikh Hasannally Esufally (MBE) as a pharmaceuticals and trading enterprise commencing operations in 1948, is listed on the Colombo Stock Exchange. Consolidated revenues in 2010-2011 were $164 million (Rs. 18, 067 million) and profits amounted to $12 million (Rs. 1,355 million). Shareholders' funds for the year were $81 million (Rs. 8,874 million). Based in Sri Lanka, Hemas takes pride in offering affordable, practical and high quality products and services in our specialised sectors of FMCG, Pharmaceutical, Hospital, Transportation, Leisure and Power. Involved in manufacturing, import, export and distribution of products, we have introduced several reputed brands to the market. We offer quality and reliable services in every possible way. Our commitment to customers is reflected in Hemas’ unparalleled service offerings which are backed by the vast experience and solid expertise of our competent team. Our unique culture brings together the values of the multiethnic island, celebrating diversity and acknowledgment of hard work. We support those with the desire and determination to strengthen their capabilities; those who thereby help the group advance in the competitive environment. Giving back to society is a practice that runs deep in the veins of Hemas. With industry sectors and networks spread across Sri Lanka in our daily business, we give back to the communities we work with. In assisting the nation at times of need, we are quick to identify requirements and help in whichever we can. In our continuous endeavor to make a positive difference in lifestyles, we at Hemas strongly believe that we’ve contributed to defining ‘comfort’, ‘satisfaction’, ‘innovation’ and ‘safety’ in the countries we serve in. Our strength, our values and our determination, will be passed down generations, embracing opportunities, ensuring that Hemas continues to enrich lives. Over the last decade the Group has been singularly focused on growth - a strategy that enabled us to emerge as leaders in several of the sectors that we are involved in. As we look to the future we are committed in our determination to widen our product and service range, expand into the international marketplace, attract the best minds, and to improve our processes.

AddLife AB markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector in the Nordics. It operates through the Labtech and Medtech segments. The Labtech segment consists of companies within diagnostics and research. It is mainly active in microbiology, clinical chemistry, coagulation, molecular biology, research, immunology, near-patient testing, veterinary diagnostics, and in the food industry. The Medtech segment provides various inhalation product solutions, mainly for home care. The company was founded on November 1, 2014 and is headquartered in Stockholm, Sweden.

Subscribe now to see 7 more clients
Subscribe now to see clients for over 2.5 million organizations
Key Stats and Financials As of 2017
Market Capitalization
Total Enterprise Value
Earnings Per Share
Net Profit
Total Debt
Total Equity
Enterprise Value Sales
Enterprise Value EBITDAOperating
TEVNet Income
Debt TEV
Three Year Compounded Annual Growth Rate Of Revenue
Five Year Compounded Annual Growth Rate Of Revenue
Subscribe now to see full financial details
Details Hidden

Rethink Medical, Inc. manufactures heart disease medical devices. It produces a remote patient physiologic monitor for predicting heart failure related hospitalizations. The company was founded by Mack Gamahewage, Reza Naima and Vivek Kesaree in 2010 and is headquartered in San Francisco, CA.

Subscribe now to see full investment details
Asahi Intecc Co. Ltd. Hospitals & Patient Services | Nagoya, AI

Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical and industrial equipment products. It operates through the Medical and Device segments. The Medical segment deals with the development, manufacture, and sale of self-branded and original equipment manufacturer products of medical equipment. The Device segment involves in the development, manufacture, and sale of parts of medical and industrial equipment. The company was founded on July 8, 1976 and is headquartered in Nagoya, Japan.

TechMatrix Corp. IT Consulting & Services | Tokyo, TY

TechMatrix Corp. engages in the sale of information technology-related software, hardware, and solutions; and provision of consulting and maintenance services. It operates through the Information Infrastructure and Application Services segments. The Information Infrastructure segment sells network, security, and storage products; and provides integration, maintenance, operation, and monitoring services. The Application Services segment offers system development, application package, cloud (Software as a Service), and test solution services. The company was founded on August 30, 1984 and is headquartered in Tokyo, Japan.

Medical Australia Ltd. Medical Products & Equipment | Sydney, NS

Medical Australia Ltd. engages in the development, manufacture and distribution of medical devices and consumables used in the human and animal healthcare markets of Australia, New Zealand and Asia. It focuses on medication delivery, reuse prevention and surgical devices. The company was founded on February 28, 2001 and is headquartered in Sydney, Australia.

Subscribe now to see 12 more suppliers
Awards & Honors
Rank #14
Forbes Magazine - The Nifty 50
Sponsored by